Britain Claiming Major Breakthrough In Prostate Cancer Treatment

In July, 2008, British researchers claimed to have wonInstitute of Cancer Research and the Royal Marsden
a major victory for prostate cancer treatment.Hospital in Britain, the symptoms of prostate cancer
According to recently release reports, a new drug,occurring in patients with advanced stages and/or
abiraterone, may be used to treat as many as 80%with untreatable forms of the disease have shown
of patients suffering from advanced forms ofsignificant regression. The news offers hope for
prostate cancer.thousands of men who contract prostate cancer
Researchers worldwide involved in the treatment ofworldwide each year.
prostate cancer are cautiously optimistic, andProstate cancer is usually diagnosed in men in the
welcoming what may arguably be the best news inlater life stages. The disease often has few
prostate cancer treatment research in the past 15symptoms early on, which is a contributing factor to
years. It is thought that larger clinical studies nowits reaching advanced stages before being detected.
need to be conducted to determine important sideBy the time men reach the ages of 40 (higher risk)
effects of the new drug's use, as well as the level ofor 50, it is recommended that they receive annual
its benefits versus the possible drawbacks of theprostate checkups. Annual checkups should include
drug treatment.both physical exams as well as blood tests, to
Abiraterone is a drug manufactured by Cougareffectively screen for the disease.
Biotechnology Incorporated, and currently beingThe American Cancer Society estimates 186,320 new
investigated for use in treatment of prostate cancer.cases, and 28,660 deaths will result from prostate
It works to block the production of testosterone,cancer in the US in 2008. The Society further states
which enhances the growth and development ofthat prostate cancer is the second leading cause of
prostate cancer, by inhibiting an enzyme involved incancer death in men in the nation.
the formation of testosterone.One in six men will get prostate cancer in his lifetime,
In drug trials of abiraterone, it appears that the drugwhile one in thirty-five men will die from the disease.
may reduce the levels of prostate specific antigenDeath from prostate cancer is currently on the
(PSA), as well as shrink prostate cancer tumors. It isdecline, a fact thought to be due to advances in
currently being tested on 1,200 men worldwide.prostate cancer treatment and early detection.
In the trials of the new drug conducted at the